| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
MYLK2 Blocking Peptide for STJ501837 is synthetically produced from the 200-250 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
MYLK2 |
| Gene ID: |
85366 |
| Uniprot ID: |
MYLK2_HUMAN |
| Immunogen Region: |
200-250 |
| Specificity: |
This blocking peptide is recommended for use in combination with MYLK2 antibody, STJ501837 |
| Immunogen: |
Synthetic peptide taken within aino acid region 200-250 on human Myosin light chain kinase 2 protein. |
| Tissue Specificity | Heart and skeletal muscles. Increased expression in the apical tissue compared to the interventricular septal tissue. |
| Function | Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain. |
| Peptide Name | Myosin Light Chain Kinase 2 - Skeletal/Cardiac MuscleMlck2 |
| Cellular Localisation | CytoplasmColocalizes With Phosphorylated Myosin Light Chain (Rlcp) At Filaments Of The Myofibrils |
| Alternative Peptide Names | Myosin Light Chain Kinase 2 - Skeletal/Cardiac Muscle proteinMlck2 proteinMYLK2 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
